186 related articles for article (PubMed ID: 36983721)
21. The predictive value of [
Gao J; Niu R; Shi Y; Shao X; Jiang Z; Ge X; Wang Y; Shao X
EJNMMI Res; 2023 Apr; 13(1):26. PubMed ID: 37014500
[TBL] [Abstract][Full Text] [Related]
22. Machine learning based evaluation of clinical and pretreatment
Nakajo M; Jinguji M; Tani A; Yano E; Hoo CK; Hirahara D; Togami S; Kobayashi H; Yoshiura T
Abdom Radiol (NY); 2022 Feb; 47(2):838-847. PubMed ID: 34821963
[TBL] [Abstract][Full Text] [Related]
23. Application of Machine Learning Analyses Using Clinical and [
Kawaji K; Nakajo M; Shinden Y; Jinguji M; Tani A; Hirahara D; Kitazono I; Ohtsuka T; Yoshiura T
Mol Imaging Biol; 2023 Oct; 25(5):923-934. PubMed ID: 37193804
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of parametrial infiltration in patients with IB-IIB cervical cancer by a radiomics model integrating features from tumoral and peritumoral regions in
Shang F; Tan Z; Gong T; Tang X; Sun H; Liu S
NMR Biomed; 2023 Apr; ():e4945. PubMed ID: 37012600
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment
Ahn HK; Lee H; Kim SG; Hyun SH
Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
[TBL] [Abstract][Full Text] [Related]
26. Machine learning based on multi-parametric magnetic resonance imaging to differentiate glioblastoma multiforme from primary cerebral nervous system lymphoma.
Nakagawa M; Nakaura T; Namimoto T; Kitajima M; Uetani H; Tateishi M; Oda S; Utsunomiya D; Makino K; Nakamura H; Mukasa A; Hirai T; Yamashita Y
Eur J Radiol; 2018 Nov; 108():147-154. PubMed ID: 30396648
[TBL] [Abstract][Full Text] [Related]
27. Can machine learning models improve early detection of brain metastases using diffusion weighted imaging-based radiomics?
Madamesila J; Tchistiakova E; Faruqi S; Das S; Ploquin N
Quant Imaging Med Surg; 2023 Dec; 13(12):7706-7718. PubMed ID: 38106308
[TBL] [Abstract][Full Text] [Related]
28. Automated differential diagnosis of dementia syndromes using FDG PET and machine learning.
Perovnik M; Vo A; Nguyen N; Jamšek J; Rus T; Tang CC; Trošt M; Eidelberg D
Front Aging Neurosci; 2022; 14():1005731. PubMed ID: 36408106
[TBL] [Abstract][Full Text] [Related]
29. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
[TBL] [Abstract][Full Text] [Related]
30. Multivariate radiomics models based on
Hu X; Sun X; Hu F; Liu F; Ruan W; Wu T; An R; Lan X
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3469-3481. PubMed ID: 33829415
[TBL] [Abstract][Full Text] [Related]
31. Predicting T-Cell Lymphoma in Children From
Yang T; Liu D; Zhang Z; Sa R; Guan F
J Imaging Inform Med; 2024 Feb; ():. PubMed ID: 38321311
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic classification of solitary pulmonary nodules using support vector machine model based on 2-[18F]fluoro-2-deoxy-D-glucose PET/computed tomography texture features.
Zhang J; Ma G; Cheng J; Song S; Zhang Y; Shi LQ
Nucl Med Commun; 2020 Jun; 41(6):560-566. PubMed ID: 32282636
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma.
Yamaguchi S; Hirata K; Kobayashi H; Shiga T; Manabe O; Kobayashi K; Motegi H; Terasaka S; Houkin K
Ann Nucl Med; 2014 Aug; 28(7):603-9. PubMed ID: 24743915
[TBL] [Abstract][Full Text] [Related]
35. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using
Jiang X; Li T; Wang J; Zhang Z; Chen X; Zhang J; Zhao X
Cancer Biother Radiopharm; 2024 Apr; 39(3):169-177. PubMed ID: 38193811
[No Abstract] [Full Text] [Related]
37. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
38. Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
Zhang H; Tan S; Chen W; Kligerman S; Kim G; D'Souza WD; Suntharalingam M; Lu W
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):195-203. PubMed ID: 24189128
[TBL] [Abstract][Full Text] [Related]
39. Machine learning based on clinico-biological features integrated
Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
[TBL] [Abstract][Full Text] [Related]
40. Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.
Kawai N; Okubo S; Miyake K; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Ann Nucl Med; 2010 Jun; 24(5):335-43. PubMed ID: 20379859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
